Upgrade to SI Premium - Free Trial

Form EFFECT Jounce Therapeutics,

May 2, 2018 6:03 AM
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: May 1, 2018 5:00 P.M.
Form: S-3
CIK: 0001640455
Company Name: Jounce Therapeutics, Inc.
File Number: 333-223518

Categories

SEC Filings